dc.creator | Hilton, Taylor | |
dc.creator | DeCrescenzo, Andrew | |
dc.creator | Menter, Alan | |
dc.creator | Chavala, Sai H. | |
dc.date.accessioned | 2021-01-19T19:19:33Z | |
dc.date.available | 2021-01-19T19:19:33Z | |
dc.date.issued | 2020-09-01 | |
dc.identifier.uri | https://doi.org/10.1016/j.jdcr.2020.07.015 | |
dc.identifier.uri | https://repository.tcu.edu/handle/116099117/43088 | |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S2352512620305063 | |
dc.description.abstract | Central serous chorioretinopathy (CSCR) is a condition defined by subretinal fluid accumulation in the area of the macula leading to serous detachment. CSCR is a significant vision-threatening retinopathy that can lead to irreversible vision loss. Although presentation can vary, the classic case comprises unilateral vision loss with the patient reporting a dark spot in the center of their visual field. Corticosteroid use has long been considered to be a factor contributing to CSCR in patients, with oral administration having the most common occurrence. However, there have been previous cases reported of CSCR presenting following topical dermal steroid use. We report a case of a patient with two separate episodes of CSCR induced by use of topical steroids. | |
dc.language.iso | en_US | en_US |
dc.publisher | Elsevier | |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.source | JAAD Case Reports | |
dc.subject | central serous chorioretinopathy | |
dc.subject | psoriasis | |
dc.subject | steroid | |
dc.title | Topical dermal steroideinduced retinopathy | |
dc.type | Article | |
dc.rights.holder | 2020 American Academy of Dermatology | |
dc.rights.license | CC BY-NC-ND 4.0 | |
local.college | Burnett School of Medicine | |
local.department | Burnett School of Medicine | |
local.persons | Chavala (SOM) | |